RNASET2 Deficiency Induces Hepatocellular Carcinoma Metastasis through Cholesterol‐Triggered MET Activation

Abstract Metastasis remains a significant challenge in the treatment of hepatocellular carcinoma (HCC). The role of ribonuclease T2 (RNASET2) in HCC is still uncertain, although it has been reported to have contradictory effects on some cancers. Here, it is demonstrated that RNASET2 knockout leads t...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yanquan Xu, Yu Chen, Jiangang Zhang, Jingchun Wang, Shuai Yang, Huakan Zhao, Lei Wu, Juan Lei, Yu Zhou, Jin Peng, Lu Jiang, Qian Chen, Rong Xin, Jianyun Zhou, Yongsheng Li
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-03-01
Series:	Advanced Science
Assuntos:	cholesterol hepatocellular carcinoma metastasis MET ribonuclease
Acceso en liña:	https://doi.org/10.1002/advs.202411888
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!